Brigantine rated Buy Dolby Laboratories (NYSE: DLB) on 06/08/2011, when the stock price was $44.74. Since then, Dolby Laboratories has lost 22.19% as of 05/21/2013's recent price of $34.81.
If you would have followed this Brigantine's recommendation on DLB, you would have lost 22.19% of your investment in 713 days.

Dolby Laboratories develops and delivers products and technologies that make the entertainment experience more realistic and immersive. For nearly four decades, Dolby has been at the forefront of defining high-quality audio and surround sound in cinema, broadcast, home audio systems, cars, DVDs, headphones, games, televisions, and personal computers. Based in San Francisco with headquarters in England, the company has entertainment industry liaison offices in New York and Los Angeles, and licensing liaison offices in London, Shanghai, Beijing, Hong Kong, and Tokyo.

Brigantine Advisors is an integrated research team with its first focus on the technology sector. The equity research analysts on our team began their careers in industry with most spending an average of 7 years in their respective sectors. In addition, each analyst has spent over 10 plus years on Wall Street and collectively they have over 100 years of experience. We provide our investment clients timely analysis of market trends by identifying major technology shifts. Within the macro environment, we identify profitable investment opportunities with a focus on both the financial and technical capabilities of the companies we analyze.

Marked as spam